These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 16669966)

  • 21. Development of a computer-aided diagnosis system for a new modality of renal replacement therapy: an integrated approach combining both peritoneal dialysis and hemodialysis.
    Hamada H; Namoto S; Yamada R; Yamashita AC; Ishizaki M; Okamoto M
    Comput Biol Med; 2005 Dec; 35(10):845-61. PubMed ID: 16310010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arteriovenous hemofiltration as an adjuvant therapy in peritoneal dialysis and hemodialysis in a patient with terminal renal failure].
    Grzegorzewska A; Czarnecki R; Wanic-Kossowska M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):692-3. PubMed ID: 1492039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
    Murashima M; Adamski J; Milone MC; Shaw L; Tsai DE; Bloom RD
    Am J Kidney Dis; 2009 May; 53(5):871-4. PubMed ID: 19339090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal dialysis in acute renal failure.
    Gabriel DP; Nascimento GV; Caramori JT; Martim LC; Barretti P; Balbi AL
    Ren Fail; 2006; 28(6):451-6. PubMed ID: 16928612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A strategy for encapsulating peritoneal sclerosis: pay attention not only to PD solution but also middle molecular uraemic substances retention!
    Yokoyama K; Hosoya T
    Nephrol Dial Transplant; 2010 Apr; 25(4):1344. PubMed ID: 20061319
    [No Abstract]   [Full Text] [Related]  

  • 26. [From CANUSA to ADEMEX: do we need a new paradigm for definition of peritoneal dialysis adequacy?].
    Enia G
    G Ital Nefrol; 2006; 23(6):569-74. PubMed ID: 17173263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of automated peritoneal dialysis: from minimum to optimum.
    Baczyński D; Antosiewicz S; Waniewski J; Marciniak M; Wańkowicz Z
    Pol Merkur Lekarski; 2003 Oct; 15(88):319-21. PubMed ID: 14974357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of adequate solute clearance in obese patients on peritoneal dialysis: a cross-sectional study.
    Shibagaki Y; Faber MD; Divine G; Shetty A
    Am J Kidney Dis; 2002 Dec; 40(6):1295-300. PubMed ID: 12460050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of dialytic modalities on clinical outcomes in ESRD patients with familial Mediterranean fever.
    Sahin S; Sahin GM; Ergin H; Kantarci G
    Ren Fail; 2007; 29(3):315-9. PubMed ID: 17497446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["Clinical clearance" and "weekly clearance" of urea in periodical hemodialytic treatment].
    Ghezzi PM; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(39):2821-3. PubMed ID: 7432691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jejunal dialysis in man using mannitol as the perfusate.
    Newstead CG
    Nephrol Dial Transplant; 1989; 4(7):658-61. PubMed ID: 2510065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous flow peritoneal dialysis: ideal peritoneal dialysis or second-rate hemodialysis?
    Bargman JM
    Contrib Nephrol; 2006; 150():321-325. PubMed ID: 16721025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urgent-start peritoneal dialysis: what are the problems and their solutions?
    Mahnensmith RL
    Semin Dial; 2014; 27(3):291-4. PubMed ID: 24621409
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical and metabolic consequences of uremic toxicity].
    Rutkowski P
    Przegl Lek; 2006; 63(4):209-17. PubMed ID: 17080744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nurse's role in prescription therapy, what does it mean?
    Lambert MC
    EDTNA ERCA J; 1997; 23(3):22-5. PubMed ID: 9664003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Dialysis of methylguanidine and hypothesis on the middle molecules].
    Barsotti G; Giovannetti S
    Ateneo Parmense Acta Biomed; 1975; 46(5):317-30. PubMed ID: 1232993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poor outcomes for fast transporters on PD: the rise and fall of a clinical concern.
    Chung SH; Heimbürger O; Lindholm B
    Semin Dial; 2008; 21(1):7-10. PubMed ID: 18251948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritoneal dialysis adequacy: not just small-solute clearance.
    Yalavarthy R; Teitelbaum I
    Adv Perit Dial; 2008; 24():99-103. PubMed ID: 18986011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.